Session Type
Meeting
Search Results for Copd
Abstract Number: 263
SHM Converge 2024
Background: Inhaled treatments are the cornerstone of management of obstructive lung disease, though patients frequently misuse inhalers, leading to worse disease outcomes. Since the COVID-19 pandemic, there has been increased interest in video-module based interventions for patients with chronic diseases. However, patients’ ability to interact with such educational resources necessitates access to technology and proficiency […]
Abstract Number: 265
Hospital Medicine 2020, Virtual Competition
Background: Hospital discharge is a complex process that requires coordination from various parties. There still remains a significant rate of readmission, with a reported 30 day readmission of roughly 20% and annual cost of $18 Billion to Medicare. Patients with adequate discharge planning have a decreased readmission rate. Recent studies that demonstrated that high risk […]
Abstract Number: 338
SHM Converge 2021
Case Presentation: Type A Lactic acidosis is commonly caused by decreased oxygen delivery and poor peripheral perfusion. Type B lactic acidosis ensues in absence of hypoxia or tissue hypoperfusion, mostly occurring in alcoholism, mitochondrial dysfunction, medications like metformin. We present an unusual case of Type B lactic acidosis induced by nebulized albuterol in the treatment […]
Abstract Number: 339
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Currently, once-daily nebulized bronchodilator therapy is unavailable for patients with chronic obstructive pulmonary disease (COPD). Prior studies demonstrated that once-daily revefenacin (REV) doses of 88 and 175 µg produced significant bronchodilation in COPD patients. We report the pooled results of two replicate phase 3 efficacy trials. Methods: In these double-blind, placebo-controlled, parallel-group, 12-week trials […]
Abstract Number: 360
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Consensus supports the use of corticosteroids in acute exacerbation of COPD (AECOPD), but route of administration and dosage still vary considerably. In one study comparing lower dose oral (PO) prednisone to higher dose intravenous (IV) methylprednisolone, the prednisone regimen was associated with comparable improvement in lung function and oxygenation but a trend toward significantly […]
Abstract Number: 476
Hospital Medicine 2020, Virtual Competition
Background: COPD is the third leading cause of death and hospital readmissions. Inpatient care for patients with COPD exacerbations varies widely across the US which can lead to patients failing to receive recommended evaluation, treatment, education, and follow-up to reduce the likelihood of recurrent exacerbations and unnecessary acute care utilization. In an effort to innovate […]
Abstract Number: 490
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: A 75 year-old man with history of type II diabetes and hypertension presented with progressive dyspnea. Two weeks prior, he had presented with similar symptoms that were attributed to COPD due to a remote history of smoking. He was hypoxic upon presentation requiring bi-level positive pressure ventilation with a FiO2 of 40%. He […]
Abstract Number: 513
SHM Converge 2021
Case Presentation: A 69 year old male with COPD and a 6-year history of a slowly progressing left upper lobe cavitary mass presented to our hospital with new hemoptysis. CT angiogram showed the cavitary mass infiltrating into an artery, as well as a pseudoaneurysm in the left lower lobe consistent with mycobacterial invasion of the […]
Abstract Number: 551
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 56-year-old male with WHO Group I/III pulmonary hypertension (PH), Gold Stage III COPD, and right ventricular failure presented with several weeks of gradually worsening dyspnea. One month prior, he was hospitalized for an acute exacerbation of PH and was discharged on an increased dose of ambrisentan after excluding intra-atrial shunting. On the […]
Abstract Number: H22
SHM Converge 2022
Background: Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) are a major driver of hospitalizations. With a goal of reducing AECOPD admissions at the Cleveland VA Medical Center (VAMC), an interdisciplinary team was developed after a literature review and discussion with high-performing VA groups. Purpose: Primary aim was to decrease AECOPD hospitalizations and readmissions at […]